Introduction
Studies of laparoscopy in colonic cancer have shown less postoperative pain, faster recovery and improved health-related quality of life (HRQL), with cancer survival rates comparable to those after open surgery 1 -4 . In regard to rectal cancer, several studies describing laparoscopic total mesorectal excision (TME) have been published, with surrogate markers indicating that it is a safe procedure. No definitive long-term survival data are yet available 3, 5, 6 .
Traditional primary outcome measures for evaluating laparoscopic surgery for rectal cancer were survival and local recurrence. However, secondary measures such as quality of life, including sexual and urinary dysfunction, are also important 7 -9 . Nerve pathways as well as microvasculature are damaged by radiotherapy, and this can be compounded by surgery 10 -14 . Sexual dysfunction after open rectal surgery has been reported in between 10 and 35 per cent of patients, but urinary dysfunction is present in less than 5 per cent 15, 16 . Reports 17 -19 of sexual and urinary dysfunction after laparoscopic TME are conflicting, indicating that more research is warranted.
The aim of this study was to compare patient-reported sexual dysfunction and micturition symptoms after rectal cancer surgery in a randomized clinical trial (COlorectal cancer Laparoscopic or Open Resection, COLOR II).
Methods
COLOR II, a non-inferiority, international, randomized clinical trial, included patients in 30 hospitals. Patients with a single rectal cancer within 15 cm from the anal verge were included, in a 2 : 1 ratio of laparoscopic to open. Patients with tumours invading adjacent tissues or organs, T4 tumours, or T3 rectal cancers within 2 mm of the endopelvic fascia at preoperative evaluation, were excluded. Further details about inclusion and exclusion criteria, randomization and clinical short-term outcomes have been reported previously 3, 20 . The protocol of the COLOR II trial was approved by the appropriate ethics committees and registered at ClinicalTrials.gov (NCT0029779).
Quality-of-life measurements
Twelve hospitals in five countries (Canada, Denmark, Germany, The Netherlands and Sweden) participated in the optional HRQL component of the COLOR II trial 21 . Inability to understand the questionnaires was an exclusion criterion. Patients who agreed to participate were asked to fill in the preoperative questionnaire before surgery. After operation the questionnaires were sent out at 4 weeks, and 6, 12 and 24 months.
Demographic data, details of preoperative radiotherapy and chemotherapy, complications during and after surgery, and the pathology report on the resected specimen were used from the clinical record forms (CRFs). At the follow-up visits (12 and 24 months), the surgeon recorded the presence of sexual dysfunction and stress urinary incontinence in the CRF.
Validated Swedish, Dutch, Danish, English and German translations of the European Organization for the Treatment of Cancer (EORTC) questionnaire QLQ-CR38 were used. This questionnaire is designed for self-administration and measures specific information about quality of life in patients with colorectal cancer. Thirty-eight questions are divided into four functional scales/single items (body image, sexual functioning, sexual enjoyment, future perspective) and eight symptom scales/items (micturition symptoms, chemotherapy side-effects, symptoms in the area of the gastrointestinal tract, male sexual problems, female sexual problems, defaecation problems, stomarelated problems and weight loss).
For this study the domains/scales/items sexual functioning, sexual enjoyment, male sexual problems, female sexual problems and micturition symptoms were used. All questions relate to the previous 4 weeks and have four alternative responses: 'not at all', 'a little', 'quite a bit' and 'very much'. The sexual functioning item comprises two questions: 'To what extent were you sexually active (with or without intercourse)?' and 'To what extent were you interested in sex?'. The answers were dichotomized into 'not at all' versus the rest ('a little', 'quite a bit', 'very much') to gauge sexual activity and sexual interest. The single item of sexual enjoyment is answered only if the patient has been sexually active. The symptom scale for male sexual problems has two items: 'Did you have difficulty getting or maintaining an erection?' and 'Did you have problems with ejaculation (such as so-called dry ejaculation)?'. In Did not participate (no informed consent, language difficulties, cognitive disability, logistical difficulties) n = 199 Values in parentheses are percentages unless indicated otherwise; *values are mean (95 per cent confidence interval). HRQL, health-related quality of life; PME, partial mesorectal excision; TME, total mesorectal excision; APR, abdominoperineal excision using TME dissection. †5 × 5 Gy or less; ‡all programmes more than 5 days. §χ 2 test, except ¶Student's t test.
Statistical analysis
The COLOR II study was powered for the primary endpoint of local recurrence at 3 years after index surgery. For this substudy a post hoc analysis was performed. The sample size achieved ( Table 1 ) corresponds to a power of 80 per cent to detect a difference in change between the two surgical procedures of around 7 points, using Student's independent-samples t test (5 per cent significance level) and assuming a standard deviation of 20 points in both samples. Applying the same principle to male sexual problems enabled detection of a difference of 10 points ( Table 1) . The domain sexual enjoyment and the symptom scale female sexual function were not analysed because response rates were low. In the EORTC questionnaires, several studies have examined the minimal important difference (MID), which represents the difference in scores corresponding to a clinically meaningful difference. Osoba 22 suggested that the MID is in the range of 5-10 points on the 100-point scale and that a difference of more than 20 points suggests a substantial change. Missing data were handled according to instructions in the EORTC score manual.
Results were calculated for the individual patient and expressed as a change from baseline before being presented as means on a group level. Comparisons of groups at baseline were made using Student's t test, χ 2 test and, where appropriate, Fisher's exact test. Function and symptom scales in the QLQ-CR38 were analysed using ANCOVA with the baseline (preoperative) score as a co-variable and surgical procedure as a factor. The results are presented as mean changes adjusted for baseline with P values and 95 per cent confidence intervals. The perspective of all statistical analyses was intention to treat. The level of significance was set at P < 0⋅050. All baseline factors and preoperative scores on functioning domains and symptom scales were considered possible confounders. To check for confounders (age, sex, body mass index, American Society of Anesthesiologists (ASA) grade, tumour stage, type of resection, preoperative radiotherapy, preoperative chemotherapy, stoma, blood loss, anastomotic leakage, duration of operation and conversion), Student's t test, ANOVA or correlation, where appropriate, were used. Confounders with P < 0.200 in the bivariable analysis were included in a multiple regression model together with surgical technique. This analysis applied to 12-month data. All statistical analyses were performed using SPSS ® 20 software (IBM, Armonk, New York, USA). Owing to the explorative nature of this study, significant P values should be interpreted with care, as interesting findings rather than conclusive evidence.
Results
Between 2004 and 2010, 1103 patients were included in the COLOR II trial; 385 patients (260 laparoscopic and 125 open) were included in this study (Fig. 1) . The patients included in the HRQL study had a lower ASA grade, a longer operating time, a smaller proportion had received preoperative radiation, and fewer had postoperative anastomotic leakage compared with the eligible patients who were not included (Tables 2 and 3) 21 . Demographic characteristics did not differ between the laparoscopic and open groups.
At 1-year follow-up, sexual dysfunction was registered in the CRFs for 29 of 326 patients (16 laparoscopic and 13 open; data missing for 59). The corresponding proportion at 2-year follow-up was 19 of 263 (11 laparoscopic and 8 open; data missing for 114 and 8 dead). There were no significant differences between the laparoscopic and open groups regarding sexual dysfunction or micturition problems at any time point (Table 4 ). Adjusting for confounders, including radiotherapy, did not change these results. Regarding radiation, none of the functioning domains and symptom scales showed a significant correlation in bivariable analysis (P > 0.200), except male sexual problems, but this was not significant in the multivariable analysis (mean score difference 12⋅4 between patients who received short preoperative radiation and those who did not receive radiation; P = 0⋅164).
All aspects of sexual dysfunction and micturition symptoms had deteriorated by 4 weeks after surgery. Sexual functioning showed a pronounced deterioration, but returned to baseline. Sexual enjoyment decreased by 6 months and stayed at a lower level throughout the study (Fig. 2) . Male sexual problems increased by 4 weeks after surgery and were relatively stable thereafter (Fig. 3) . Changes over time in sexual activity and sexual interest are shown in Fig. 4 . Sexual activity was decreased at 4 weeks after surgery, but recovered partially. There were differences between men and women regarding both sexual interest and activity.
Before surgery 64⋅5 per cent of the men in the laparoscopic group reported some degree of erectile dysfunction compared with 55⋅6 per cent in the open group (P = 0⋅253). Corresponding values were 81⋅1 and 80⋅5 per cent 4 weeks after surgery (P = 0⋅933), and 76⋅3 and 75⋅5 per cent respectively at 12 months (P = 0⋅912).
Discussion
There were no differences in sexual dysfunction and micturition symptoms after laparoscopic versus open surgery for rectal cancer. Sexual dysfunction was more pronounced than micturition symptoms, regardless of technique. As in previous studies 16, 23 , it was found that women showed less interest and had lower sexual activity than men. In the setting of the randomized Conventional versus Laparoscopic-Assisted Surgery In Colorectal Cancer (CLASICC) trial 18 , in which EORTC QLQ-CR38 questionnaires were collected prospectively and the International Index of Erectile Function (IIEF) was added retrospectively, there were no significant differences in sexual function between laparoscopic and open surgery for rectal cancer 18 . Quah and colleagues 17 reported a significant difference in male sexual dysfunction between patients undergoing laparoscopic and open rectal cancer surgery, in favour of open surgery. That study was based on retrospective interviews and questionnaires (IIEF) 3 years after surgery for about 50 per cent of the patients in a randomized trial 17 , and the results should be evaluated in view of these methodological shortcomings. In a retrospective study 24 of 173 patients treated in a single centre by an expert laparoscopic surgeon, there was a significant difference in sexual function in favour of laparoscopic compared with open surgery. As previously indicated by Stephens and colleagues 12 , radiotherapy has less effect on sexual dysfunction than surgery.
The main strengths of the present study are the prospective and randomized design, population size, collection of baseline data, reporting of HRQL at several time points, and the use of validated and established instruments. The weaknesses include that the HRQL part of the COLOR II study was optional for participating centres and had a relatively low inclusion rate (62⋅4 per cent of those eligible), with a small but significant selection bias regarding ASA grade, preoperative radiation, rate of anastomotic leakage and duration of operation between eligible patients who did not participate and included patients. There were differences between the laparoscopic and open surgery groups in operating time and blood loss, concordant with findings in the total COLOR II trial cohort 3 .
The same group of patients had a response rate of approximately 90 per cent 21 for other parts of the QLQ-CR38 questionnaire, whereas for the scales or symptoms reported in this study the response rates varied between 8⋅2 and 90⋅9 per cent. In the EORTC instrument there is a structural problem regarding the symptom scale female sexual problems as the questions are tied to the condition of sexual intercourse during the past 4 weeks. This may in part explain the low response to this symptom scale. Owing to its international design, this study was restricted to using instruments validated in many languages. The instrument has a heteronormative approach with sexual penetration as the norm. On the other hand, it is possible that some patients may be offended by sexual questions insinuating homosexual behaviour or masturbation, which could influence the response rates 25 .
The low frequency of CRF-reported complications regarding sexual dysfunction contrasted with the higher frequency of problems reported by patients in the questionnaires. This emphasizes the need for patient-reported outcomes as a complement to the surgeon's records when evaluating postoperative morbidity.
